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Received January 20, 2013; accepted September 13, 2013AbstractBackground: Ginsenoside Rg1 (Rg1) is believed to be one of the main active principles in ginseng, a traditional Chinese medicine extensively
used to enhance stamina and deal with fatigue as well as physical stress. It has been reported that Rg1 performs multiple biological activities,
including neuroprotective activity. In this study, we investigated the efficacy of ginsenoside Rg1 on ischemiaereperfusion injury in cultured
hippocampal cells and also probed its possible mechanisms.
Methods: To establish a model of oxygeneglucose deprivation (OGD) and reperfusion, cultured hippocampal neurons were exposed to OGD for
2.5 hours, followed by a 24-hour reoxygenation. Cultured hippocampal neurons were randomly divided into control group, model group
(vehicle), and ginsenoside Rg1 treatment groups (5mM, 20mM, 60mM). At 24 hours post-OGD, the intracellular free calcium concentration was
detected using Furo-3/AM-loaded hippocampal neurons deprived of oxygen and glucose. Neuronal nitric oxide synthase (nNOS) activity was
measured by chemical colorimetry. Cell apoptosis was evaluated by Hoechst staining, and the neuron viability was determined by 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay.
Results: Excitotoxic neuronal injury of OGD was demonstrated by the increase of intracellular free calcium concentrations and elevated nNOS
activity in the model group compared with the control group. The intracellular free calcium concentrations and the nNOS activity in the groups
receiving intermediate and high dose of ginsenoside Rg1 were significantly lower than those of the control group (p < 0.05). In addition,
intermediate and high dose of ginsenoside Rg1 administration could also attenuate the cell viability loss (p < 0.05) and cell apoptosis induced
by OGD.
Conclusion: Ginsenoside Rg1 has neuroprotective effect on ischemiaereperfusion injury in cultured hippocampal cells mediated by blocking
calcium over-influx into neuronal cells and decreasing the nNOS activity after OGD exposure. We infer that ginsenoside Rg1 may serve as a
potential therapeutic agent for cerebral ischemia injury.
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Ischemic cerebral stroke is a devastating event that has
become the third greatest cause of mortality and the leading
cause of disability worldwide, and results in many serious
physical, psychological, and social difficulties. However, the
treatment of stroke still remains highly unsatisfactory. A va-
riety of clinical trials of pharmacological neuroprotective
strategies in stroke have been demonstrated to behinese Medical Association. All rights reserved.
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for cerebral stroke management in order to improve clinical
prognoses in patients with brain ischemic injury is urgent.
Ginseng, the root of Panax ginseng C.A. Meyer (Aral-
iaceae), a well-known traditional Chinese medicine, has been
widely used to enhance stamina and deal with fatigue as well
as physical stress for thousands of years in oriental countries.2
Ginsenosides, or ginseng saponins, are widely considered to
among the principal bioactive constituents of ginseng, and
provide diverse benefits due to their structural isomerism and
stereoisomerism.3 Up to now, over 30 different ginsenosides
have been isolated and identified from ginseng, and they are
classified into two major groups: protopanaxadiol and proto-
panaxatriol saponins, according to their chemical structures.3
Recently, the effects of different kinds of ginsenosides have
been extensively studied, and a great spectrum of pharmaco-
logical responses has been reported, including effects on the
central nervous system, cardiovascular system, endocrine
system, immune system, and cancer.3,4 Neuronal cell damage,
including apoptosis, is the principal event occurring in the
acute and subacute phases of cerebral ischemia. Ginsenoside
Rg1 (Fig. 1),5 belonging to the protopanaxatriol group, is an
important active component of ginseng. The neuroprotective
effects of ginsenoside Rg1 have been extensively investigated
recently in several cell-damaging models, such as glutamate
and kainic acid-induced excitotoxicity insults in spinal neu-
rons,6 rotenone-induced degeneration of cells in the substan-
tial nigra,7 glutamate-induced excitotoxic effect in primary
hippocampal cultures,8 serum withdrawal-induced apoptosis
in primary cultured cortical neurons,9 glutamate induced in
dopaminergic cell loss10 and 1-methyl-4-phenyl-pyridiniumþ-
induced apoptosis in human SHSY5Y cells.11 However, little
work has been done in hypoxiceischemic conditions.
Furthermore, the detailed mechanisms underlying theFig. 1. The chemical structure of ginsenoside Rg1. The molecular formula of
ginsenoside Rg1 is C42H72O14, and the molecular weight is 801.01.neuroprotective efficacy of ginsenoside Rg1 still await
investigation.
The maintenance of Ca2þ homeostasis is important for cell
function and survival, conversely, intracellular calcium
([Ca2þ]i) overload is believed to be one of the first events
triggered by brain ischemia.12,13 Nitric oxide (NO) is a ubiq-
uitous messenger molecule that also acts as a neuronal
messenger molecule in the central nervous system. NO has
been demonstrated to be produced enzymatically in response
to activation of N-methyl-D-aspartate (NMDA) receptors.14
This activation results in an elevated influx of Ca2þ ions
into the postsynaptic structure, which in turn activates NO-
synthase (NOS) under physiological conditions.14e16 Prior
studies have demonstrated that NOS mediates the ischemia-
induced neuronal damage.17 The present investigation was
designed mainly to evaluate the role of Rg1 on Ca2þ influx and
the activity of neuronal NOS (nNOS) in experimental stroke
models induced by oxygeneglucose deprivation (OGD).
2. Methods2.1. ReagentsGinsenoside Rg1 was isolated and purified at China Phar-
maceutical University (Nanjing, China). Neuronal NOS
detection kit was provided by Nanjing Jiancheng Bioengi-
neering Institute (Nanjing, China). Poly-L-lysine, glutamine,
trypsin, and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetra
zolium bromide (MTT) were purchased from Sigma-Aldrich
(St Louis, MO, USA). Fetal horse serum, Dulbecco’s modi-
fied Eagle medium (DMEM), Neurobasal, and B27 were ob-
tained from Invitrogen Gibco (Carlsbad, CA, USA). Fetal
bovine serum was provided by Sijiqing Biological Engineer-
ing Institute (Hangzhou, China). Hoechst 33258 fluorescent
dye kit was obtained from Beyotime Institute of Biotech-
nology (Jiangsu, China). All other chemicals were of the
purest grade available from regular commercial sources.2.2. Primary rat hippocampal cell cultureProtocols were in accordance with the International
Guidelines for Animal Research and were approved by the
Animal Care and Experimental Committee of Nanjing Medi-
cal University (Jiangsu, China). Hippocampi were aseptically
dissected out from embryonic Day 18 SpragueeDawley rat
embryos acquired from the Experimental Animal Center of
Nanjing Medical University. Hippocampal neurons were
dissociated from the tissues as previously described else-
where.18 After trituration and trypsinization, hippocampal
cells were resuspended in DMEM supplemented with 10%
fetal bovine serum, 10% horse serum, glutamine 100 mg/mL,
and penicillin/streptomycin (100 U/mL and 100 mg/mL,
respectively). The single-cell suspension was seeded in 35 mm
petri dishes or 96-well plates (Corning Inc., Corning, NY,
USA) coated with poly-L-lysine at a density of (2e5)  105/
mL. After 24 hours, cells were maintained in Neurobasal
medium supplemented with 2% B27, penicillin/streptomycin
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mosphere of 5% CO2 at 37
C.2.3. OGD model establishmentPrimary hippocampal neuronal cultures were incubated in
deoxygenated, glucose-free medium to mimic the interruption
of the supply of oxygen and nutrients to the brain parenchyma.
Hippocampal neuronswere cultured in vitro for 8e10 days prior
to being randomly divided into control group, model group
(vehicle), ginsenoside Rg1 intervention group (low-, interme-
diate-, and high-dose). The number of cells in each group was
counted in four 20 fields, and all of them were equal (about
120e150 cells/20 fields). Ginsenoside Rg1 of different con-
centrations (5mM, 20mM, and 60mM) was added to the culture
medium 30 minutes prior to OGD. The culture medium was
replaced by prewarmed DMEM with low glucose (1 g/L) in the
model group and ginsenoside Rg1 intervention group, whereas
the control group received high-glucose (4.5 g/L) DMEM. The
cultures were then transferred to a hypoxia chamber containing
gas mixture of equilibrated 95%N2/5%CO2 for 2.5 hours at
37C. OGDwas terminated by placing the cultures back into the
normoxic incubator with normal culture medium. Sham OGD
cultures were exposed in normoxic conditions during the same
period of time as the OGD cultures. Twenty-four hours after
OGD procedures, neuron cultures were terminated to run tests.2.4. [Ca2þ]i measurement using Fluo-3-AM-based
microfluorimetryTo observe the possible influence of Rg1 on the elevated
[Ca2þ]i induced by OGD, the fluorescence intensity was
detected 24 hours after OGD. The procedures of OGD model
establishment and Rg1 treatment have been described above.
At 24 hours post-OGD, the existing maintenance medium was
carefully discarded and the hippocampal cells were washed
with PBS three times. For loading with Fluo-3-AM, the hip-
pocampal cells were incubated without light for 30 minutes at
37C with a final concentration of 10mM Fluo-3-AM. Once
dye-loaded, the cells were washed thoroughly with the assay
buffer to remove any unincorporated dye. The intensity of
fluorescence was recorded with the excitation wavelength at
488 nm and emission wavelength at 525 nm using a Zeiss
LSM-510 laser scanning confocal microscope (Carl Zeiss,
Jena, Germany). The [Ca2þ]i was estimated from the fluo-
rescence signal, accounting for the binding of calcium to the
dye. All the fluorescence image data were collected and
analyzed with the LSM510, version 2.3 software (Carl Zeiss).2.5. Neuronal NOS determinationHippocampal cells were collected when cell culture was
terminated 24 hours after OGD as mentioned above. After
being washed with PBS, hippocampal cells were lysed with
cell lysis buffer, followed by which supernatant was discarded
after centrifugation at 4C, 16,000g for 10 minutes. The nNOS
activity was measured by chemical colorimetry according tothe manufacturer’s instructions. There were no endothelial
cells and inflammatory cells involved in the cultured hippo-
campal cells, suggesting that determined NOS activity was
totally attributed to nNOS.2.6. Cell viability assayCell viability was evaluated by the MTT assay, which is
based on the reduction of MTT by the mitochondrial dehy-
drogenase of intact cells to form a purple formazan product as
described previously.19 In brief, at 24 hours post-OGD, 20 mL
of MTT solution (5 mg/mL) was added to each well and the
plates were incubated at 37C for another 4 hours. The me-
dium was then replaced by 100 mL DMSO and the amount of
formed purple formazan dye was determined by measuring the
absorbance value at a wavelength of 490 nm using a micro-
plate reader (Bio-Rad Laboratories, Hercules, CA, USA).
Each experiment was performed using six replicated wells for
each group and carried out independently three times.2.7. Fluorescence analysis of apoptosisHippocampal cells were stained with Hoechst 33258 ac-
cording to the manufacturer’s instructions for the Hoechst
Staining Kit (Beyotime Institute of Biotechnology) to detect the
characteristic features of apoptotic nuclei. The cultured hippo-
campal neurons were fixed in ice-cold 4% phosphate-buffered
paraformaldehyde overnight and then incubated at room tem-
perature with 1 g/mL Hoechst 33258 dye (Beyotime Institute of
Biotechnology) for 5 minutes. Cells were analyzed under an
inverted phase-contrast fluorescence microscope at 400
magnification and counted by a blinded investigator from three
independent experiments. The cultured hippocampal cells with
fragmented DNA, condensed DNA, or normal DNA were
counted. The ratio of apoptotic neurons to total neurons was
calculated. In each experiment, 200 cells were examined in
random fields from three culture wells for each condition to
estimate the percentage of apoptotic hippocampal cells.2.8. Statistical analysisResults are expressed as mean  standard error of the
mean. Data were statistically evaluated by one-way analysis of
variance (ANOVA) to determine differences among the
groups. A probability level of p < 0.05 was accepted as sta-
tistically significant. All statistical analyses were performed
with SPSS 11.5 (SPSS Inc., Chicago, IL, USA) software.
3. Results3.1. Effect of ginsenoside Rg1 on OGD-induced [Ca2þ]i
increaseAfter being stained with Fluo-3 AM, hippocampal neurons
emitted fluorescence excited by an argon laser of 488 nm
wavelength (Fig. 2). The effect of ginsenoside Rg1 on [Ca2þ]i
in hippocampal cells after OGD is shown in Fig. 3. [Ca2þ]i of
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with the control group. However, compared with the model
group, [Ca2þ]i of intermediate and high dose (20mM, 60mM,
respectively) ginsenoside Rg1 intervention groups of
decreased significantly (p < 0.05), whereas such variation did
not occur in the low-dose (5mM) ginsenoside Rg1 intervention
group. Pretreatment with relatively high concentration (20mM,
60mM) of ginsenoside Rg1 inhibited OGD-induced [Ca2þ]i
increase; however, the amplitude of decline was not statisti-
cally different between the two groups. In addition, pretreat-
ment with a low concentration of ginsenoside Rg1 (5mM) did
not affect the OGD-induced [Ca2þ]i response.Fig. 3. Effect of ginsenoside Rg1 on oxygeneglucose deprivation (OGD)-
induced [Ca2þ]i increase. To observe the possible influence of Rg1 on the3.2. Effect of ginsenoside Rg1 on OGD-induced nNOS
activity increaseelevated [Ca2þ]i induced by OGD, Rg1 was added 30 minutes prior to the
procedure of OGD, and the fluorescence intensity was detected 24 hours after
OGD procedures. The data are means  standard error of the mean from three
The nNOS activity of hippocampal cells in the OGD group
was significantly elevated (p < 0.05) compared with that in theFig. 2. Representative microphotographs of hippocampal neurons that emitted
fluorescence when excited by an argon laser of 488 nm wavelength after being
stained with Fluo-3 AM (original magnification 400) by using a Zeiss LSM-
510 laser scanning confocal microscope.
independent experiments. Statistical significance was evaluated by one-way
analysis of variance. p < 0.05 was regarded as statistically significant.
* p < 0.05 versus model group (OGD).control group. Compared with the model group, the nNOS
activity of the intermediate and high dose (20mM, 60mM,
respectively) ginsenoside Rg1 intervention groups of
decreased significantly (p < 0.05); however, the low-dose
(5mM) ginsenoside Rg1 intervention group did not reach sta-
tistical significance compared with the model group. Pre-
treatment with a relatively high concentration (20mM, 60mM)
of ginsenoside Rg1 inhibited OGD-induced elevated nNOS
activity. However, pretreatment with a low concentration of
ginsenoside Rg1 (5mM) did not significantly affect the OGD-
induced elevated nNOS activity (Fig. 4).3.3. Effect of ginsenoside Rg1 against OGD-induced
cytotoxicityThe possibility that ginsenoside Rg1 can have a direct
protective effect on hippocampal neurons against ischemia/
reperfusion injury was detected by analyzing the effect of
ginsenoside Rg1 on OGD-induced neuronal death by MTT
assay. As shown in Fig. 5, exposure of hippocampal neurons to
150 minutes of OGD induced significant cell death at 24 hours
after reperfusion. The cell survival in the control group was
standardized to 100%. Pretreatment with a relatively high
concentration (20mM, 60mM) of ginsenoside Rg1 inhibited
OGD-induced neuronal death with a significant elevation of
neuronal survival rate (p < 0.05), whereas a low dose (5mM)
of ginsenoside Rg1 slightly increased hippocampal neuronal
viability compared with the model group, but did not reach
statistical significance.3.4. Effect of ginsenoside Rg1 on OGD-induced
apoptosisTo better characterize the effects of ginsenoside Rg1 on
OGD-induced neuronal cell death, Hoechst 33258 (Beyotime
Fig. 4. Effect of ginsenoside Rg1 on oxygeneglucose deprivation (OGD)-
induced neuronal nitric oxide synthase (nNOS) activity increase. The neuronal
NOS activity was measured by chemical colorimetry according to the manu-
facturer’s instructions in the assay kits. The data are mean  standard error of
the mean from three independent experiments. Statistical significance was
evaluated by one-way analysis of variance. p < 0.05 was regarded as statis-
tically significant. * p < 0.05 versus model group (OGD). ** p < 0.05 versus
control group.
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OGD insult in the presence or absence of ginsenoside Rg1.
Exposure to OGD also resulted in apoptotic death of hippo-
campal neurons, as revealed by the appearance of condensed
(bright blue) nuclei in Hoechst-stained cultures (Fig. 6A). A
total of 200 cells spotted on glass slides from randomly chosen
microscopic fields were examined and counted by fluores-
cence microscopy, and the percentage of cells exhibiting
apoptotic degeneration relative to the total number was
calculated as the apoptotic index from three independent ex-
periments. Through cell counting, it was determined that
46.94  3.14% of cultured neurons were apoptotic at 24 hoursFig. 5. Effect of ginsenoside Rg1 on oxygeneglucose deprivation (OGD)-
induced cytotoxicity. 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide (MTT) assay was conducted to evaluate the protective efficacy of
ginsenoside Rg1 on hippocampal neurons against ischemia/reperfusion injury.
The data are mean  standard error of the mean shown as percentages of the
viability of the control group from three independent experiments. Each
experiment was performed using six replicated wells for each group. Statistical
significance was evaluated by one-way analysis of variance. p < 0.05 was
regarded as statistically significant. * p < 0.05 versus model group (OGD).post-OGD, as compared to 5.24  0.92% of neurons apoptotic
in the total population of the control group. However, treat-
ment with ginsenoside Rg1 (5mM, 20mM, 60mM) significantly
decreased OGD-induced apoptotic cell death, with the per-
centage of apoptotic neurons being 44.24  4.27%,
36.24  2.75%, and 34.32  2.18%, respectively. Pretreat-
ment with relatively high concentrations (20mM, 60mM) of
ginsenoside Rg1 inhibited OGD-induced elevated hippocam-
pal neuronal apoptotic index (p < 0.05), whereas a low dose
(5mM) of ginsenoside Rg1 slightly decreased OGD-induced
hippocampal neuronal apoptotic index, but did not reach sta-
tistical significance (Fig. 6).
4. Discussion
In the present study, we investigated whether treatment of
primary cultures of rat hippocampal cells with ginsenoside
Rg1 was able to prevent neurotoxicity resulting from OGD.
The present data in our cell-damaging models highlight that
ginsenoside Rg1, one of the active ginsenosides, exhibited
protective effects against neuronal damage induced by hypo-
xiceischemic insults. We found that Rg1 improved neuronal
viability and ameliorated apoptotic rate in cultured hippo-
campal neurons after OGD. Moreover, with Rg1 treatment,
elevated intracellular Ca2þ concentrations and nNOS activity
induced by OGD were markedly inhibited, suggesting that the
neuroprotective activities of Rg1 were mediated by blocking
calcium over-influx into neuronal cells and attenuating nNOS
activity. These results suggest that Rg1 could prove to be a
novel therapeutic candidate for the treatment of ischemic ce-
rebral stroke.
Ginsenosides are amphiphilic and have the ability to
intercalate into the plasma membrane, which leads to alter-
ations in membrane fluidity and affects membrane function.3
The effects of ginsenosides may be initiated at the plasma
membrane by interacting with multireceptor systems,20 as well
as via intracellular protein binding to produce genomic effects.
Accumulated evidence has been found to demonstrate the
neuroprotective effects of ginsenosides. Ginsenosides may
rescue neuronal cells by increasing cell survival, extending
neurite growth, and protecting neurons from death either
in vivo or in vitro.10,21,22 Ginsenosides have been exhibited to
act as antioxidants, or scavengers for free radicals, by
increasing the activity of superoxide dismutase and inhibiting
lipid peroxidation.23 In addition, ginsenosides upregulate
nerve growth factor expression, which in turn promotes neuron
survival.24 Furthermore, ginsenosides could protect cortical
neurons from glutamate insults by blocking Ca2þ influx
through glutamate receptors.25 Thus, Rg1, a single ginseno-
side, may also exhibit diverse functions by interacting with
multireceptor systems.3 Studies have demonstrated that Rg1 is
able to increase dopamine content in the striatum.26 Much
work has been done to find Rg1 to be protective in some cell-
damaging models in recent years. Liao et al6 observed that
Rg1 could protect spinal neurons from excitotoxicity induced
by glutamate and kainic acid, as well as oxidative stress
induced by H2O2 in a dose-dependent way. In a glutamate
Fig. 6. Effect of ginsenoside Rg1 on oxygeneglucose deprivation (OGD)-induced apoptosis. The apoptosis of hippocampal cells in each group was examined by
Hoechst staining. Cells were harvested and fixed in ice-cold 4% phosphate-buffered paraformaldehyde overnight and examined under an inverted phase-contrast
fluorescence microscope at 400 magnification by staining with Hoechst 33258 dye. (A) Normal control group. (B) Model group: hippocampal neurons subjected
to OGD. (C) Low dose of ginsenoside Rg1: hippocampal neurons subjected to OGD in the presence of 5mM Rg1. (D) Intermediate dose of ginsenoside Rg1:
hippocampal neurons subjected to oxygen-glucose deprivation in the presence of 20mM Rg1. (E) High dose of ginsenoside Rg1: hippocampal neurons subjected to
OGD in the presence of 60mM Rg1. The figure represents three experiments with similar results. Hoechst 33258 dye was used to stain the DNA of the shrunken
nuclei and the chromatin condensation in nuclei in the fluorescence pictures.
147Q. He et al. / Journal of the Chinese Medical Association 77 (2014) 142e149excitotoxic model, Liu and Zhang8 found that Rg1 increased
the cell viability and reduced the LDH release of cortical
neurons. Li et al9 reported that Rg1 inhibited the apoptosis of
the cultured cortical neurons with serum withdrawal. Leung
et al7 showed that Rg1 exerted a protective effect on nigral
neurons against rotenone toxicity. Radad et al10 documented
that ginsenoside Rg1 had a partial neurotrophic and neuro-
protective effect in dopaminergic cell culture stressed with
glutamate.
The results of our present study are consistent with most of
these findings. Physiological Ca2þ signals are indispensable
for cell function and survival, whereas Ca2þ overload or
perturbations of intracellular Ca2þ compartmentalization can
activate or promote mechanisms leading to cell death. Alter-
ations of intracellular Ca2þ storage can integrate with death
signals to promote processing of cellular components and
death by apoptosis or necrosis. Furthermore, Ca2þ can directly
activate catabolic enzymes such as proteases, phospholipases,
and nucleases that directly cause cell demise.13 In neurons, the
Naþ/Ca2þ exchanger and ATP-driven plasma membrane Ca2þ
pump are involved in the plasma membrane Ca2þ extrusion
systems to regulate the intracellular Ca2þ content so that Ca2þ
fluctuations are kept within physiological level.27 It is
generally accepted that calcium overload is involved in
ischemic brain injury.12,13 In pathological conditions,
including cerebral ischemia, a massive glutamate release leads
to glutamate neurotoxicity. The neurotoxicity is mainly due to
activation of NMDA receptors, which cause excessive eleva-
tion of [Ca2þ]i and subsequent neuronal cell death.28 Eleva-
tion of [Ca2þ]i following NMDA receptor activation also
stimulates NOS.
NO is generated from the amino acid L-arginine by NOSs.
Mammals contain three NOS isoforms: nNOS, inducible NOS,
and endothelial NOS.29 NO is a messenger molecule that has
numerous molecular targets. Neuronal NOS is expressed inspecific neurons of the brain, the activity of which is regulated
by Ca2þ and calmodulin. Neuronal NOS has been implicated
in modulating physiological functions, such as learning,
memory, and neurogenesis. Abnormal NO signaling is very
likely to be involved in a variety of neurodegenerative pa-
thologies, including excitotoxicity following stroke.30 Hyper-
active nNOS, stimulated by massive Ca2þ influx into neuronal
cells, has been implicated in NMDA receptor-mediated
neuronal death in cerebrovascular stroke. Under these condi-
tions, NO contributes to excitotoxicity, probably via perox-
ynitrite activation of poly adenosine diphosphate-ribose
polymerase and mitochondrial permeability transition. High
levels of NO can also exert energy depletion, owing to inhi-
bition of mitochondrial respiration and glycolysis.31,32
In the present study, cultured hippocampal neurons were
subjected to OGD to mimic the cerebral ischemia injury. After
OGD insult, intracellular free Ca2þ concentration of hippo-
campal neurons markedly increased, probably via activating
ionotropic and metabotropic glutamate receptors. We showed
that Rg1 inhibits the increase of Ca2þ influx in hippocampal
neurons subjected to OGD. Recently, Zhang et al33 reported
that inhibition of Rg1 on NMDA receptors and L-type voltage-
dependent Ca2þ channels may be potentially involved. In
addition, nNOS activity resulting from OGD was significantly
elevated, which was attributed to stimulation of massive Ca2þ
influx into hippocampal neurons.17 The elevated nNOS ac-
tivity was markedly inhibited by Rg1 treatment. We may hy-
pothesize that it is partially attributable to inhibition of Ca2þ
influx mediated by NMDA receptors and L-type voltage-
dependent Ca2þ channels. However, whether other mecha-
nisms are attributable to this phenomenon remain to be
elucidated. Hence, ginsenoside Rg1 attenuates OGD-induced
neuronal cell death by inhibition of both [Ca2þ]i increase
and Ca2þ-dependent nNOS activity. It is suggested that the
neuroprotective effect of Rg1 is probably mediated by the
148 Q. He et al. / Journal of the Chinese Medical Association 77 (2014) 142e149inhibition of Ca2þ influx to maintain the Ca2þ homeostasis
and keep an appropriate nNOS activity. Given that the overall
pharmacology of ginsenosides is complex, it is likely that
other factors in addition to Ca2þ and nNOS activity stabilizing
effects may also contribute to the actions of ginsenoside Rg1.
Therefore, more studies on pharmacological mechanisms of
neuroprotective actions and toxicity of ginsenoside Rg1 are
required.
In conclusion, ginsenoside Rg1 exerted a neuroprotective
effect on OGD hippocampal neurons, which was probably
mediated by the inhibition of Ca2þ influx and nNOS activity,
suggesting that, at least in part, the protective actions resulted
from inhibition of Ca2þ signaling. As a result, neuronal
viability was elevated and apoptotic neurons diminished in
number. However, the molecular mechanisms that underlie the
protective actions of ginsenosides are not fully understood.
Even so, ginsenoside Rg1 may serve as a potential therapeutic
agent for cerebral ischemia injury, and further in vivo studies
on stroke should be encouraged to confirm the potential neu-
roprotective effects of Rg1.
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